Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Supernus Pharmaceuticals Inc., 3 years.
Supernus Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Supernus Pharmaceuticals Inc. | Open-market sale | −5,369 | $50.61 | $271,725 |
| Feb 24, 2026 | Supernus Pharmaceuticals Inc. | Grant or award | +4,475 | — | — |
| Jan 9, 2026 | Supernus Pharmaceuticals Inc. | Option exercise | +15,000 | $12.98 | $194,700 |
| Aug 14, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −7,457 | $42.26 | $315,133 |
| Feb 22, 2025 | Supernus Pharmaceuticals Inc. | Grant or award | +5,369 | — | — |
| Jan 22, 2025 | Supernus Pharmaceuticals Inc. | Option exercise | +20,000 | $9.13 | $182,600 |
| Nov 8, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −8,722 | $36.28 | $316,434 |
| Feb 23, 2024 | Supernus Pharmaceuticals Inc. | Grant or award | +3,886 | — | — |
| Nov 15, 2023 | Supernus Pharmaceuticals Inc. | Option exercise | +7,457 | $9.24 | $68,903 |
| Nov 15, 2023 | Supernus Pharmaceuticals Inc. | Open-market sale | −3,882 | $28.50 | $110,637 |
| Nov 15, 2023 | Supernus Pharmaceuticals Inc. | Open-market sale | −5,211 | $28.50 | $148,514 |
| Feb 22, 2023 | Supernus Pharmaceuticals Inc. | Grant or award | +3,882 | — | — |
| Jan 10, 2023 | Supernus Pharmaceuticals Inc. | Option exercise | +8,722 | $7.90 | $68,904 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.